Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Goldman Sachs Group
(NY:
GS
)
614.00
+8.12 (+1.34%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Goldman Sachs Group
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
99
100
Next >
2025 London Financial District Competition – Asia-Pacific Region Participants
December 24, 2024
Via
Binary News Network
Here's How Much $100 Invested In Goldman Sachs Gr 5 Years Ago Would Be Worth Today
December 23, 2024
Via
Benzinga
Chinese Self-Driving Firm Pony AI’s Stock Gets 2 'Buy' Calls On Wall Street: Retail Gets Extremely Bullish
December 23, 2024
Goldman Sachs projects positive EBITDA and net income by 2030.
Via
Stocktwits
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst Conviction
December 23, 2024
Goldman Sachs analyst maintains Buy rating on Pfizer with $33 price target. Discusses update on 2nd-gen C. diff vaccine in Phase 2. Data expected in 2025.
Via
Benzinga
Why Broadcom (AVGO) Stock Is Up Today
December 23, 2024
Shares of fabless chip and software maker Broadcom (NASDAQ:AVGO) jumped 5.3% in the afternoon session after UBS analyst Timothy Arcuri raised his price target by $50 to $270 in a research note. The...
Via
StockStory
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Check Out What Whales Are Doing With Goldman Sachs Gr
December 20, 2024
Via
Benzinga
Behind the Scenes of Goldman Sachs Gr's Latest Options Trends
December 18, 2024
Via
Benzinga
It's a Sporting Time of Year. Time to Take a Look at Academy Sports and Outdoors.
December 23, 2024
We also answer listener questions about diversification in the S&P 500.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
"Motley Fool Money" Looks Back at Financials Stocks in 2024
December 23, 2024
It's been a banner year for banks. Even the worst performer among the big players is up 40% year-to-date.
Via
The Motley Fool
Pony AI Speeds Past Competitors, Commercializes Fully Driverless Vehicles
December 23, 2024
Pony AI, a Chinese autonomous driving tech leader, debuted on Nasdaq in Nov. Goldman Sachs says it has the largest Level 4 fleet in China. Analyst Allen Chang gave a Buy rating and $19.60 price target,...
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Today (Dec. 18) Is a Big Day for the Stock Market
December 18, 2024
Via
The Motley Fool
Why Value Stocks Are the Best Bet Today—and Goldman Sachs Agrees
December 23, 2024
Now that the value vs. growth spreads are bottoming at multi-year lows, investors should start considering potential buys in this value list.
Via
MarketBeat
Topics
Bonds
ETFs
Economy
Exposures
Debt Markets
Interest Rates
Goldman Sachs Has Updated Its Economic Projections For 2025
December 23, 2024
Goldman Sachs updated its economic projections to reflect nuanced changes in monetary policy expectations and global growth trends for 2025.
Via
Talk Markets
Topics
Commodities
Stocks / Equities
MarketBeat Week in Review – 12/16 - 12/20
December 21, 2024
Stocks were lower this week after the Federal Reserve confirmed fewer rate cuts in 2025, but Friday's rally suggests hope for a Santa Claus rally remains strong
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Why Warren Buffett Stock Nu Holdings Dived by 13% This Week
December 20, 2024
Via
The Motley Fool
Spot Market Trends With These 3 Must-Watch ETFs
December 20, 2024
There are major divergences and convergences in different ETFs today, which investors need to consider for their portfolios.
Via
MarketBeat
Topics
Bonds
ETFs
Economy
Exposures
Debt Markets
Economy
Interest Rates
10 Biggest Losers of The Dow Jones Index's 10-Day Losing Streak
December 19, 2024
Investors shrugged off the meltdown on Thursday. A few Dow laggards rebounded.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
AI Writing: It Needs Help from Humans – But Only if They Are Good Writers by WriteSmart.org
December 19, 2024
Surprising responses from Meta.ai to questions about how humans can improve AI writing
Via
PRUnderground
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Block Positioned For Margin Expansion And EPS Growth: Goldman Sachs Analyst
December 19, 2024
Analyst reiterates Buy rating on SQ with $102 price target, expecting growth in gross profit, margin expansion, and GPV acceleration in 2025.
Via
Benzinga
SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
December 19, 2024
For for those of us who are looking at SolarEdge with a fresh pair of eyes, there are a few reasons to be excited, albeit cautiously.
Via
MarketBeat
InvestorNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) to Present at Goldman Sachs Energy Conference
December 19, 2024
Via
Investor Brand Network
Topics
Supply Chain
Exposures
Supply Chain
Consumer Finance Watchdog Cracks Down on Credit Card Sneaky Fees and False Promises
December 18, 2024
CFPB announces measures to protect consumers from deceptive credit card practices, including new research and a comparison tool. Companies may face penalties for misleading users and failing to deliver...
Via
Benzinga
Topics
Credit Cards
Exposures
Interest Rates
Ozempic Dethroned? A Head-to-Head Study Confirms This Company Has the Best Weight Loss Drug
December 18, 2024
Via
The Motley Fool
SolarEdge Poised For Growth Amid Cost Cuts, While Canadian Solar Faces US Policy Headwinds: Goldman Sachs
December 17, 2024
Goldman Sachs analyst Brian Lee revised ratings for residential solar stock, upgrading SolarEdge and downgrading Canadian Solar due to policy risks.
Via
Benzinga
10 Financials Stocks With Whale Alerts In Today's Session
December 17, 2024
Via
Benzinga
Why Is SolarEdge (SEDG) Stock Soaring Today
December 17, 2024
Shares of solar power systems company SolarEdge (NASDAQ:SEDG) jumped 17.6% in the morning session after the stock received a double rating upgrade from Goldman Sachs. The firm upgraded Solar Edge from...
Via
StockStory
This Clean Energy Stock Surges On Upgrade Despite Trump Uncertainty
December 17, 2024
Goldman Sachs handed SolarEdge a buy rating and a price target hike late Monday.
Via
Investor's Business Daily
Topics
Government
Exposures
Political
1 Vanguard Index Fund to Buy to Beat the S&P 500 in 2025, According to a Wall Street Bank
December 17, 2024
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
AMC Entertainment Stock Dips to 2-Month Low, Sparks Retail Chatter
December 17, 2024
Recently, AMC said it plans to conduct another stock sale of 50 million shares through Goldman Sachs, with plans to use the proceeds to pay down debt and upgrade locations.
Via
Stocktwits
What To Expect When Pfizer Outlines Its 2025 Financial Outlook On Tuesday?
December 16, 2024
Pfizer's 2025 guidance to be revealed Tuesday. Goldman Sachs predicts $64.9 billion revenue and EPS of $3.13, supported by Paxlovid and Eliquis growth.
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.